HMS
DYN icon

Hanseatic Management Services’s Dyne Therapeutics DYN Stock Holding History

Hanseatic Management Services’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,183
Closed -$258K – 123
2024
Q3 		$258K Buy
+7,183
New +$286K 0.37% 57

Other funds holding DYN

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Hanseatic Management Services's DYN Position: Q4 2024 in Review

Hanseatic Management Services sold out of Dyne Therapeutics (DYN) in Q4 2024, closing a stake of 7,183 shares — an estimated $258K sold.

Hanseatic Management Services first reported a position in DYN in Q3 2024 and held it in 1 quarter. The position peaked at $258K in Q3 2024. 200 funds tracked by Wall St. Rank hold DYN as of Q4 2024.

  • Hanseatic Management Services reported no remaining Dyne Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Hanseatic Management Services sold 7,183 Dyne Therapeutics shares in Q4 2024, an estimated $258K.
  • Hanseatic Management Services first reported a position in Dyne Therapeutics in Q3 2024 and held it in 1 quarter.
  • Hanseatic Management Services's Dyne Therapeutics position peaked at $258K in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q4 2024.

Based on Hanseatic Management Services's 13F filing for Q4 2024, filed 15 Jan 2025.